Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis

Summary

This study consists of two phases (Phase I and Phase IIa). Phase IIa will be conducted sequentially after the safety of SCM-AGH is secured in Phase I. * Phase I: Multicenter in Korea, Non-Randomized, Open-label, Single Arm, 3+3 design) for Severe Acute Pancreatitis * Phase II: Multicenter in Korea, Randomized, Double-blind, 2-arm, Placebo-controlled, Parallel arm for Moderate to Severe Acute Pancreatitis

Timeline

Start

2019-08-12

Primary completion

2022-01-14

Completion

2022-03-15

Drugs

Indications